FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, pharmacology and chemical-pharmaceutical industry, namely to a new polymorphous form of trimebutine maleate and a pharmaceutical composition in solid form, having spasmolytic activity, wherein said composition contains a therapeutically effective amount of a novel polymorphic form of trimebutine maleate and at least one pharmaceutically acceptable carrier.
EFFECT: there are disclosed new polymorphous forms of trimebutine maleate, a method of producing and using it.
3 cl, 1 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW POLYMORPHIC FORMS OF TRIMEBUTINE MALEATE, METHOD FOR PRODUCTION AND APPLICATION | 2019 |
|
RU2770300C2 |
| NEW POLYMORPHIC FORMS OF TRIMEBUTINE MALEATE, METHOD FOR PRODUCTION AND APPLICATION | 2019 |
|
RU2770301C2 |
| RETARD TABLETS OF TRIMEBUTINE | 2013 |
|
RU2536254C1 |
| PHARMACEUTICAL COMPOSITION IN FORM OF HARD PERORAL DRUG FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES | 2009 |
|
RU2418576C2 |
| COMBINATION FOR TREATING FUNCTIONAL GASTROINTESTINAL DISEASES | 2019 |
|
RU2733719C1 |
| COMPOSITIONS OF TETRAHYDROBIOPTERINE AND METHODS OF ITS QUANTITATIVE ASSESSMENT | 2008 |
|
RU2486899C2 |
| MEDICATION FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | 2020 |
|
RU2744125C1 |
| MACROCYCLIC POLYMORPHS, COMPOSITIONS CONTAINING SUCH POLYMORPHS, AND METHODS FOR USING AND PREPARING THEM | 2008 |
|
RU2478643C2 |
| ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION FOR TREATING IRRITABLE BOWEL SYNDROME, CONTAINING INTESTINAL PERISTALSIS CONTROLLER, AGENT PREVENTING DELAY OF GASES, AND DIGESTIVE ENZYMES, AND PREPARATION METHOD THEREOF | 2011 |
|
RU2581920C2 |
| USE OF TRIMEBUTINE MALEATE FOR PREVENTING AND TREATING INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT | 2024 |
|
RU2821790C1 |
